SEC FORM 4
$2,563,516.53
Amneal Pharmaceuticals, Inc. (AMRX)
Sale of 146,403 shares at $17.51 per share.
Reporting Person Shah Nikita · Officer Title Executive Vice President · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001628280-26-056757 · filed 2026-08-13 · View filing →